Table 2 Effects of ZnPcS ₄ -AN-based PDT and/or Dox treatments on erythrogram parameters of healthy and Ehrlich solid tumor-bearing mice

1

NC

8.8 ± 0.1

12.8 ± 0.1

31.5 ± 0.3

35.8 ± 0.1

14.5 ± 0.1

40.5 ± 0.2

13.01 ± 0.09

2

CT

8.6 ± 0.2

12.0 ± 0.2

30.7 ± 0.5

35.7 ± 0.3

13.9 ± 0.1**^a

38.9 ± 0.2**^a

13.6 ± 0.3

3

ZnPc

6.6 ± 0.7**^a.*^b

9.2 ± 0.9**^a.*^b

23.3 ± 2.5**^a.*^b

35.6 ± 0.4

14.2 ± 0.3

39.9 ± 0.5

14.1 ± 0.7

4

LS

8.5 ± 0.1*^a.c

11.9 ± 0.2**^c

30.5 ± 0.5*^a.**^c

36.0 ± 0.1

14.08 ± 0.08**^a

39.1 ± 0.2**^a

13.1 ± 0.2

5

PDT

8.1 ± 0.2**^a.*^b.d

11.4 ± 0.3**^c

29.0 ± 0.6**^a.*^b

35.7 ± 0.2

14.0 ± 0.1

39.2 ± 0.2

14.0 ± 0.3

6

Dox

7.8 ± 0.3

11.1 ± 0.3

30 ± 1

38 ± 2

14.1 ± 0.3

38 ± 1**^a

13.5 ± 0.4

7

ZnPc/Dox

8.0 ± 0.4*^a

10.9 ± 0.5

28 ± 1**^a

35.25 ± 0.05

13.60 ± 0.00*^a.d

38.50 ± 0.00*^a.c.d

13.8 ± 0.4

8

Dox/LS

7.6 ± 0.4**^a.*^b.d

10.9 ± 0.5*^a

27 ± 1*^a.d.**^b

35.8 ± 0.7

14.3 ± 0.1*^b

39.9 ± 0.5

13.5 ± 0.6

9

Dox/PDT

8.3 ± 0.2^.*^c.h

11.8 ± 0.2**^c

30.1 ± 0.6*^a.**^c

36.2 ± 0.3

14.18 ± 0.12*^g

39.2 ± 0.1**^a.*^g

14.2 ± 0.3

P-values

0.000

0.000

0.000

0.195

0.018

0.000

0.033